- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.11. | Neuralink rival Paradromics cleared to start speech trial | ||
| 21.11. | Alnylam's ATTR cardiomyopathy drug backed for NHS use | ||
| 21.11. | ADC specialist Solve raises $120m, and other biofinancings | ||
| 21.11. | GSK unit and AnaptysBio trade lawsuits over Jemperli | ||
| 20.11. | NICE backs five AI tools for bowel cancer screening | ||
| 20.11. | Merck partners Valo on $3bn, AI-based Parkinson's project | ||
| 20.11. | Advocate slams muted response to UK male health strategy | ||
| 20.11. | Bayer takes on Boehringer with FDA nod for lung cancer drug | ||
| 20.11. | Medscape launches genAI clinical support tool | ||
| 19.11. | Agios shares slump on sickle cell disease data | ||
| 19.11. | Alkermes offers more for Avadel after Lundbeck bid | ||
| 19.11. | Bayer gets EU approval for menopause drug Lynkuet | ||
| 19.11. | Approvals extend use of Roche, AbbVie drugs in lymphoma | ||
| 19.11. | US vulnerable to China's API dominance, says report | ||
| 18.11. | GSK pumps £45m into antimicrobial resistance projects | ||
| 18.11. | Roche extols 'unprecedented' result with breast cancer drug | ||
| 18.11. | New guidance covers AI-based biomarkers for cancer care | ||
| 18.11. | Novo Nordisk cuts Wegovy price ahead of TrumpRx launch | ||
| 17.11. | Sandoz launches first biosimilar Tysabri in US | ||
| 17.11. | J&J swoops on cancer biotech Halda with $3bn takeover deal | ||
| 17.11. | BMS, J&J give up on milvexian for acute coronary syndrome | ||
| 17.11. | Filmmaker helps AbbVie spread the word about leukaemia | ||
| 17.11. | Sofinnova Partners raises €650m for early-stage biotechs | ||
| 17.11. | Sarepta rises after FDA adds warning label to Elevidys | ||
| 14.11. | Sanofi's type 1 diabetes drug poised for EU rollout |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .